Skip to content

Clinical trials

Phase 3 Diabetes Mellitus, Type 1 trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 1 Phase: Phase 3 Country / region: Australia Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20022
20031
20041
20074
20092
20111
20121
20131
20141
20153
20161
20172
20191
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Recruiting3
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S11
Eli Lilly and Company7
AstraZeneca2
Boehringer Ingelheim2
Lexicon Pharmaceuticals1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
Sanofi1
University of Cambridge1
University of Glasgow1
University of Sydney1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 128
Diabetes Mellitus12
Diabetes Mellitus, Type 22
Retinal Diseases2
Asthma1
Diabetic Nephropathies1
Diabetic Neuropathies1
Diabetic Retinopathy1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.